Serum biochemical changes in rabbits on a regular diet with and without flax lignan complex following a high-cholesterol diet

International Journal of Angiology

Volumn 17, Issue 1, 2008, Pages 27-32

  Prasad, Kailash ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Alanine aminotransferase; Albumin; Alkaline phosphatase; Aspartate aminotransferase; Cholesterol; Creatinine; Flax lignan complex; Gamma glutamyltransferase; Glucose; Serum electrolytes

Indexed keywords

EID: 74349108419     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1278276     Document Type: Article

References (18)

1. Westcott ND, Paton D. Complex containing lignan, phenolic and aliphatic substances from flax and process for preparing. http://www.freepatentsonline. com/6264853.html (Version current at March 6, 2008).
2. Prasad K. Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol Cell Biochem 1997;168:117-23. (Pubitemid 27091062)
3. Prasad K. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 2000;9:220-5.
4. Foti M, Piattelli M, Baratta MT, Ruberto G. Flavonoids, coumarins, and cinnamic acids as antioxidants in a micellar system. Structure-activity relationship. J Agric Food Chem 1996;44:497-501. (Pubitemid 126469456)
5. Lupien PJ, Moorjani S, Brun D, Bielmann I. Effects of 3-hydroxy-3-methylglutaric acid on plasma and low-density lipoprotein cholesterol levels in familial hypercholesterolemia. J Clin Pharmacol 1979;19:120-6. (Pubitemid 9119659)
6. Prasad K. Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis 2005;179:269-75. (Pubitemid 40364620)
7. Prasad K. A study on regression of hypercholesterolemic atherosclerosis in rabbits by flax lignan complex. J Cardiovasc Pharmacol Ther 2007;12:304-13. (Pubitemid 350264697)
8. Prasad K. Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Atherosclerosis 2008;197:34-42. (Pubitemid 351273270)
9. Prasad K, Lee P. Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism. Atherosclerosis 2007;192:313-22. (Pubitemid 46726333)
10. Xu G, Stoffers DA, Habener J F, Bonner-Weir S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999;48:2270-6. (Pubitemid 30395416)
11. Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 2005;329:386-90. (Pubitemid 40255465)
12. Mölgaard J, von Schenck H, Olsson AG. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia. Eur J Clin Pharmacol 1989;36:455-60. (Pubitemid 19135207)
13. Mabuchi H, Nohara A, Kobayashi J, et al. Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: A randomized double-blind study. Atherosclerosis 2007;195:e182-9. (Pubitemid 350087984)
14. Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 2005;11:BR228-34. (Pubitemid 40992191)
15. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000;45:1929-34.
16. Hatzitolios A, Savopoulos C, Lazaraki G, et al. Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia. Indian J Gastroenterol 2004;23:131-4. (Pubitemid 39145721)
17. Ravel R. Clinical Laboratory Medicine: Clinical application of laboratory data, 6th ed. St Louis: Mosby-Year Book Inc, 1995:309-30.
18. Ravel R. Clinical Laboratory Medicine: Clinical application of laboratory data, 6th ed. St Louis: Mosby-Year Book Inc, 1995:166-77.